135 results
Page 5 of 7
8-K
EX-99.1
958w5
26 Feb 20
Regulation FD Disclosure
4:29pm
8-K
EX-1.1
v8hnwi5
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
424B5
utgxowjqpa1q
21 Feb 20
Prospectus supplement for primary offering
4:26pm
424B5
12lzg
20 Feb 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.1
t4b5rk43jg
12 Feb 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
okqo2ctbnn6s7jsi2hr
8 Jan 20
Results of Operations and Financial Condition
4:31pm
424B5
8v7 fktg8d
8 Nov 19
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
ym78al15pnf1yxvxg
2 Aug 19
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:50pm
424B5
3b4 b7jbfdwkpo
2 Aug 19
Prospectus supplement for primary offering
4:40pm
424B5
fh3037ahik1 2ryw1s
1 Aug 19
Prospectus supplement for primary offering
4:21pm
8-K
0uebffv u4mbuf
22 Jul 19
Agile Therapeutics Appoints Chief Financial Officer
5:23pm
8-K
EX-10.1
bgsn7yccn0 vt0qgfns
4 Mar 19
Agile Therapeutics Announces $7.8 Million Private Placement
5:27pm
424B5
910zthaahus2qmou2o5
23 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
EX-99.1
4okx7w ke2tgb6
7 Jan 19
Results of Operations and Financial Condition
8:01am